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Emerging evidence suggests that ubiquitination serves as a
protein trafficking signal in addition to its well characterized
role in promoting protein degradation. The yeast G protein 
subunit Gpa1 represents a rare example of a protein that under-
goes bothmono- andpoly-ubiquitination.Whereasmono-ubiq-
uitinated Gpa1 is targeted to the vacuole, poly-ubiquitinated
Gpa1 is directed instead to the proteasome. Here we investigate
the structural requirements for mono- and poly-ubiquitination
ofGpa1.We find that variants ofGpa1 engineered tobeunstable
are more likely to be poly-ubiquitinated and less likely to be
mono-ubiquitinated. In addition, mutants that cannot be myr-
istoylated are no longer mono-ubiquitinated but are still poly-
ubiquitinated. Finally, we show that the ubiquitin ligase Rsp5 is
necessary for Gpa1 mono-ubiquitination in vivo and that the
purified enzyme is sufficient to catalyzeGpa1mono-ubiquitina-
tion in vitro. Taken together, these data indicate thatmono- and
poly-ubiquitination have distinct enzyme and substrate recog-
nition requirements; whereas poly-ubiquitination targets mis-
folded protein for degradation, a distinct ubiquitination appa-
ratus targets the fully mature, fully myristoylated G protein for
mono-ubiquitination and delivery to the vacuole.
Cell surface receptors transmit external sensory and chemi-
cal stimuli to the intracellular space via G proteins. In yeast, G
protein-coupled receptors initiate a signaling cascade that leads
to new gene transcription, cell cycle arrest, morphological
changes, and eventually mating.Mating is the process by which
a and  cells fuse to form an a/ diploid cell. This mating proc-
ess is initiated by cell type-specific peptide pheromones; hap-
loid a-type cells secrete a-factor pheromone, which binds to
receptors on the surface of -type cells, whereas -type cells
secrete -factor that acts exclusively on a-type cells (1).
Transmission of the pheromone signal requires a receptor, a
heterotrimeric G protein complex including , , and  sub-
units, and a series of protein kinases as well as a transcription
factor. As with other G protein systems, pheromone binding to
its receptor stimulates an exchange of GDP for GTP on the G
subunit (Gpa1), which induces a conformational change and
dissociation from the G (Ste4/18) subunit complex (1, 2).
The dissociated G in turn transmits and amplifies the signal
to effector proteins that produce an intracellular response. Sig-
naling persists until GTP is hydrolyzed to GDP by the G sub-
unit, which promotes its re-associationwithG. Thus, theG
subunit serves primarily to regulate the levels of free G.
Indeed, cells lacking the G subunit gene cannot sequester
G, resulting in permanent activation of the mating response
and cell cycle arrest (3, 4). Recent evidence suggests that the
GTP-activatedG subunit can alsomodulate signaling through
a direct interaction with phosphatidylinositol 3-kinase in yeast
(5).
Given their function asmediators between cell surface recep-
tors and intracellular effectors, G proteins are well positioned
to serve as targets of regulation. Indeed, G proteins undergo a
variety of modifications including (i) phosphorylation, (ii) myr-
istoylation, (iii) palmitoylation, and (iv) ubiquitination (6–8).
Of these modifications, the least characterized is phosphoryla-
tion. Gpa1 is phosphorylated at serine 200 (9), and phosphoryl-
ation in this case appears to precludemyristoylation.3However,
the responsible kinase and the upstream stimulus have not been
identified. Another major modification is N-myristoylation,
which is an irreversible process that occurs co-translationally
on most G proteins including yeast Gpa1. Myristoylation of
Gpa1 is required to promote proper plasma membrane local-
ization and heterotrimeric G protein complex formation (10).
Yeast mutations in theN-myristoyltransferase (NMT1) gene or
mutations that replace the myristoylated glycine-2 residue of
Gpa1 result in constitutive activation of the pheromone
response pathway (11). A third modification is palmitoylation.
Nearly all G proteins including Gpa1 are palmitoylated (7, 12,
13). Palmitoylation of G subunits is post-translational, revers-
ible, and largely dependent on priormyristoylation and delivery
to the plasma membrane (14, 15). Finally, ubiquitination is the
process by which a protein is covalentlymodified by addition of
a single (mono) or polymeric (poly) formof ubiquitin (16). Gen-
erally speaking, mono-ubiquitinated substrates are recognized
by a cellular trafficking machinery that transports the target
protein to the vacuole (the yeast counterpart to the lysosome),
where it is degraded by resident vacuolar proteases (17). Poly-
ubiquitinated substrates, on the other hand, are recognized and
degraded by the proteasome protease complex (18).
Emerging evidence suggests that ubiquitination acts largely
as a trafficking signal in addition to its well documented role as
a degradation signal (17, 19). Restated, a protein that undergoes
mono- or poly-ubiquitination must first translocate to either
the vacuole or the proteasome before it can be degraded. This
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trafficking function is well documented for mono-ubiquiti-
nated plasmamembrane proteins such as Ste2 and Ste3 (17, 20,
21). Poly-ubiquitination has likewise been demonstrated to act
as a trafficking signal for some plasma membrane proteins. For
example, the mammalian V2 vasopressin receptor and the 2
adrenergic receptor are internalized and degraded in a poly-
ubiquitin-dependent manner (22, 23). In some instances such
as the insulin-like growth factor I receptor, both lysosomal and
proteasomal pathways are employed, further suggesting that
either mono- or poly-ubiquitination can serve as a trafficking
signal for membrane-bound proteins (24).
Ubiquitination plays a particularly important role in regula-
tion of the yeast mating response. Of the pheromone signaling
components, either mono- or poly-ubiquitination has been
reported for the cell surface receptors Ste2 and Ste3 (20, 21), the
G protein  subunit Gpa1 (25, 26), the GTPase accelerating
protein Sst2 (27), and the downstream protein kinase Ste7 (28,
29). Mono-ubiquitination of Ste2 and poly-ubiquitination of
Ste7 and Sst2 are induced by pheromone, and these modifica-
tions are thought to represent feedback loops leading to pher-
omone desensitization (in the case of Ste2 and Ste7) and resen-
sitization (in the case of Sst2).
Whereas a large number of proteins undergo ubiquitination,
only a few are known to undergo both mono- and poly-ubiq-
uitination. Prominent examples include the human tumor sup-
pressor p53 (30), proliferating cell nuclear antigen (31), and the
general amino acid permease Gap1 (32). Such examples have
the potential to reveal the regulatory mechanisms and func-
tional consequences for each type of ubiquitin modification,
each acting on the same protein substrate.
Gpa1 has been shown to undergo both mono- and poly-
ubiquitination, and available evidence suggests that these
two processes are distinct (25, 26). In yeast lacking Pep4, an
aspartyl protease required for activation of vacuolar pro-
teases (33), Gpa1 accumulates in the mono-ubiquitinated
formandbecomes visibly concentrated in vacuoles (26). In con-
trast, yeast harboring a temperature-sensitive mutation in
Cim3, a subunit required for proteasomal protease activity (34),
exhibit elevated Gpa1 poly-ubiquitination and accumulation in
the cytoplasm (26). Here we show that Gpa1 mono- and poly-
ubiquitination are catalyzed by different ubiquitin ligases, each
having distinct substrate requirements, andwith different func-
tional consequences; whereas poly-ubiquitination is a traffick-
ing signal used for turnover of misfolded or structurally unsta-
ble protein, mono-ubiquitination serves as a trafficking signal
for the turnover of fully myristoylated, fully mature protein.
More generally, these findings reveal how a single protein is
targeted for two different forms of ubiquitination, each having
profoundly distinct consequences for trafficking and degrada-
tion of the substrate.
EXPERIMENTAL PROCEDURES
Strains and Plasmids—Standard methods for growth, main-
tenance, and transformation of yeast and bacteria for the
manipulation of DNA were used throughout. Yeast Saccharo-
myces cerevisiae strains used in this study were BY4741 (MATa
leu2 met15 his3 ura3), BY4741-derived mutants lacking
PEP4 (pep4::KanMX, Research Genetics, Hunstville, AL),
LHY488 (MATa his3-200 leu21 ura3-52 lys2-801 trp163
ade2-101), LHY489 (LHY488 cim3-1) (provided by Linda
Hicke, Northwestern University), YGS5 (MATa ura3-52 lys2
ade2oc trp1 leu2-1 gpa1::hisG ste11ts) (10), and ste7 gpa1
(BY4741, ste7::KanMX, gpa1::hisG) in which the GPA1 open
reading frame was disrupted by integration of a HisG-URA3-
HisG cassette followed by counter-selection with 5-fluoro-
orotic acid as described previously (10). Doxycycline-sensitive
yeast strains (MATa URA3::CMV-tTA his3-1 leu2-0 met15-0)
were purchased as part of the yeast Tet-promoter Hughes Col-
lection (yTHC,OpenBiosystems) described inMnaimneh et al.
(35).
Yeast shuttle plasmids used here were pAD4M (2 m ampR
LEU2 ADH1 promoter/terminator), pAD4M-GPA1, pRS406-
GPA1-GFP (26), pRS316-GPA1, which contains GPA1 under
the control of its native promoter (10), pRS423-FUS1-lacZ (36),
and pRS405-GPA1-GFP-pep4. pRS405-GPA1-GFP-pep4 was
constructed by first cloning theGPA1 open reading frame plus
600 base pairs of upstream promoter sequence into the XbaI/
ClaI sites of pUG35 vector (provided by Johannes Hegemann,
Heinrich-Heine-Universität), which places GPA1 in-frame
with green fluorescent protein (GFP).4 The resulting GFP
fusion was subcloned from pUG35 (including the pUG35 ter-
minator sequence) into the XbaI/EagI sites of pRS405 (Strat-
agene). The DNA fragment corresponding to base pairs 239–
782 of the PEP4 gene was cloned into the XhoI site of the
resulting pRS405-GPA1-GFP vector. The resulting plasmid
was linearized with BbvCI (New England Biolabs) and inte-
grated at the PEP4 locus, simultaneously disrupting the PEP4
gene and introducing GPA1-GFP.
All point mutations were constructed using the QuikChange
site-directed mutagenesis kit (Stratagene). Oligonucleotide











Computational Protein Stability Estimation—Identification
of destabilizing mutations in yeast Gpa1 was accomplished
usingMedusa proteinmodeling software (37).Medusamodels
a protein in atomic resolution and features a physical force
field as well as a rapid amino acid side-chain packing algo-
rithm to accurately recapitulate changes in protein fold sta-
bility upon amino acid substitution (38, 39). Because the struc-
ture of yeast Gpa1 is unknown, we used its mammalian
ortholog, Gi, as the modeling system. Gi exhibits 67% se-
quence similarity with Gpa1, and the Gi structure has been
solved by high resolution x-ray crystallography (PDBcode 1agr)
(40). Using Medusa, we systematically evaluated the predicted
4 The abbreviations used are: GFP, green fluorescent protein; DTT, dithiothre-
itol; DIC, differential interference contrast; 4K, four lysine; Ub, ubiquitin.
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stability change upon substitution of each native amino acid
with alanine along the entireGi sequence. The stability of each
mutant was computed with the relaxed structure, and the
mutation-induced stability change (G) was obtained by sub-
tracting the wild type stability (39). Finally, the destabilizing
mutations were mapped onto the yeast Gpa1 sequence, and
only conserved residues were considered further. To minimize
the likelihood of disrupting G protein function, we avoided
mutating residues associated with nucleotide catalysis, confor-
mational changes (switch regions), or other known protein
binding regions (2).
Growth, Transcription, and Protein Turnover Assays—Phero-
mone-dependent growth inhibition (halo) and reporter-tran-
scription assays were conducted as described previously (36).
Doxycycline repressible strains (TetO7-ORF) were grown to
early log phase, then diluted with selectable media containing
doxycycline hyclate (Sigma-Aldrich) at 10 g/ml final concen-
tration, grown to early log phase (A600 nm  1.0), and harvested.
To evaluate Gpa1 stability in the absence of protein translation,
early-log phase cultures were treated with cycloheximide at 10
g/ml final concentration, and aliquots were harvested at the
indicated time points. Unless otherwise noted, all cells were
harvested by the addition of 1 M NaN3 (10 mM final concentra-
tion), centrifugation, washing with ice-cold 10 mM NaN3, and
stored at 80 °C. Protein extracts were generated by glass bead
lysis in trichloroacetic acid as described previously (41),
resolved by 10% SDS-PAGE, and transferred to nitrocellulose
membranes. The resulting membranes were probed with Gpa1
antibodies at 1:1000 (42). Immunoreactive species were visual-
ized by chemiluminescent detection (PerkinElmer Life Sci-
ences LAS) of horseradish peroxidase-conjugated anti-rabbit
IgG (Bio-Rad).
Microscopy—Cells were visualized by differential interfer-
ence contrast (DIC) and fluorescence microscopy using an
Olympus Fluoview 1000 confocal microscope, with the follow-
ing laser lines: 488 nm (blue argon, for GFP) and 633 nm (red
helium neon for DIC). Images (12-bit Tiff) were analyzed using
ImageJ (NIH).
Escherichia coli Expression of Glutathione S-Transferase-
and His6 Fusion Proteins—pLIC-HIS-GPA1 plasmids were
generated by ligation-independent cloning as described previ-
ously (43). GPA1 was PCR-amplified from genomic DNA
(forward primer, 5-TACTTCCAATCCAATGCGATGGGG-
TGTACAGTGAGTAC-3; reverse primer, 5-TTATCCACT-
TCCAATGCGCTATATAATACCAATTTTTTTAAGGTT-
TTGC-3), annealed to the gapped His6 vector pMCSG7 (from
Jason Snyder and John Sondek, University of North Carolina),
and transformed into BL21-CodonPlus (DE3)-RIPL E. coli
(Stratagene). An overnight culture from a single colony grown
at 37 °C in 2 YT (yeast extract and Tryptone) with 100 g/ml
carbenicillin was diluted 1:100 in fresh medium and grown to
A600 nm  0.6 followed by inductionwith 0.2mM isopropyl-D-
1-thiogalactopyranoside and incubation at room temperature
for 5 hwith shaking. Cells were harvested by centrifugation and
resuspended in lysis buffer (20 mM Tris, pH 8.0, 400 mM NaCl,
2 mM MgCl2, 25 mM Imidazole, 1 mM DTT, 5% glycerol) sup-
plemented with 20 M GDP and proteinase inhibitor tablets
(Roche Applied Science). The cell suspension was homoge-
nized with an Emulsiflex-C5 homogenizer (Avestin), and the
resulting lysate was cleared by two centrifugations, one at
2,000 g for 15min and a second at 45,900 g for 30min. The
supernatant was incubated with lysis buffer-equilibrated Ni-
SepharoseTM 6 Fast Flow resin (General Electric) for 2 h rotat-
ing at 4 °C. The resin was harvested by centrifugation and
washed 4 times with lysis buffer followed by elution with lysis
buffer containing 250 mM Imidazole. The elution was simulta-
neously mixed with His-tagged tobacco etch virus protease (to
remove the N-terminal 6HIS fromGpa1) and dialyzed in 1 liter
of dialysis buffer (20mMTris, pH 8.0, 100mMNaCl, 1mMDTT,
5% glycerol, 20MGDP) overnight followed by incubationwith
Ni-Sepharose resin for 1 h to remove tobacco etch virus prote-
ase and cleavage products. Flow-through from the Ni-Sepha-
rose was concentrated using Vivaspin concentrators (Viva-
science AG).
Rsp5, Ubc5, and protein kinase A (PKA)-ubiquitin (ubiquitin
containing a cAMP-dependent protein kinase phosphorylation
site suitable for radioactive phosphorylation) were expressed
from the pET21b expression vector (Novagen) in BL21p E. coli
(Stratagene). Glutathione S-transferase-Rsp5 expression was
induced by the addition of 0.33 mM isopropyl -D-1-thiogalac-
topyranoside at 16 °C overnight. Lysates were generated by
sonication in lysis buffer A (1 phosphate-buffered saline, 1
mM DTT) followed by ultracentrifugation at 15,000  g. The
cleared supernatant was passed over a GSTrap column (Amer-
sham Biosciences), washed, and then eluted by thrombin (Sig-
ma-Aldrich) cleavage overnight at 4 °C in elution buffer (50mM
Tris pH 8.0, 1 mM DTT). The cleaved protein was passed over
GSTrap again and the flow-through was collected and further
purified by anion exchange chromatography using HiTrap Q
(Amersham Biosciences). Ubc5 and protein kinase A-ubiquitin
expression was induced by the addition of 0.33 mM isopropyl
-D-1-thiogalactopyranoside at 25 °C overnight. Lysates were
generated as above but in lysis buffer B (50 mM NaPO4 pH 7.6,
500mMNaCl, 20mM imidazole, 5mM -mercaptoethanol) and
then passed over HiTrap His (Amersham Biosciences) fol-
lowed by elution in lysis buffer B containing 500 mM imidaz-
ole and dialyzed into 50 mM Tris, pH 8.0, 1 mM DTT. The
dialyzed protein was further purified by anion exchange
(HiTrap Q) and size exclusion chromatography (S75 resin)
(Amersham Biosciences).
In Vitro Ubiquitination Assay—1 M human E1 activating
enzyme Uba1 (Boston Biochem), 1 M yeast E2 conjugating
enzyme Ubc5, and 0.2 M yeast E3 ligase Rsp5 (or the cata-
lytically inactive mutant Rsp5C777A) were incubated with 0.2
M Gpa1, 5 M protein kinase A-ubiquitin, and 4.8 mM ATP
(Sigma-Aldrich) in 1 ubiquitination buffer (25mMTris, pH
7.5, 50 mM NaCl, 4 mM MgCl2) for 30 min at room temper-
ature. Reactions were quenched by adding SDS-PAGE load-
ing buffer containing 100 mM DTT followed by SDS-PAGE
and immunoblotting with anti-Gpa1 antibody as described
above.
RESULTS
Myristoylation Is Required for Mono-ubiquitination of Gpa1—
It is well established that Gpa1 is myristoylated, palmitoylated,
phosphorylated, and either mono-ubiquitinated or poly-ubiq-
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FIGURE 1. Myristoylation is required for mono-ubiquitination of Gpa1. A, anti-Gpa1 immunoblot of strain BY4741 transformed with an overexpression
plasmid (pAD4M) containing either wild type GPA1 (WT), gpa1G2A (G2A), gpa1S200A (S200A), or the double mutant as indicated. B, DIC and fluorescence
microscopy images of BY4741 transformed with an integrating plasmid (pRS406) containing the native GPA1 promoter and either wild type GPA1 or the
indicated mutant fused to the yeast-enhanced GFP (left). C, pheromone-induced growth inhibition assay of strain (ste7 gpa1) transformed with single copy
plasmids pRS315-STE7 and either pRS316-GPA1 or pRS316-GPA1S200A, with each gene under the control of its native promoter. Transformed cells were plated
onto solid medium and exposed to paper discs containing -factor pheromone (clockwise from left: 1.5, 4.5, 15, and 45 g). D, cells expressing FUS1-lacZ
reporter and overexpressing (pAD4M) Gpa1 or Gpa1S200A treated with the indicated concentrations of mating pheromone for 90 min. Results are the mean 
S.E. for three individual experiments each performed in triplicate. E and F, a proteasomal protease-defective mutant (cim3-1), a vacuolar protease-deficient
mutant (pep4), or the corresponding isogenic wild type strains transformed with plasmid pAD4M-GPA1, pAD4M-gpa1S200A, or pAD4M-gpa1G2A and analyzed
by immunoblotting with anti-Gpa1 antibodies. Note that all lanes shown within a single panel are from a single gel and are treated identically through all stages
of image acquisition. Poly-ubiquitinated Gpa1 (Gpa1-(Ub)n), mono-ubiquitinated Gpa1 (Gpa1-Ub), myristoylated, and non-myristoylated Gpa1 (Gpa1) and
common nonspecific bands (*) are indicated. Top and bottom panels are identical except for exposure time.
G Protein Mono-ubiquitination by the Rsp5 Ubiquitin Ligase
MARCH 27, 2009 • VOLUME 284 • NUMBER 13 JOURNAL OF BIOLOGICAL CHEMISTRY 8943
uitinated. Our objective here was to determine the structural
determinants leading to mono- versus poly-ubiquitination of
Gpa1. The data available suggest that myristoylation and
mono-ubiquitination are coordinately regulated, as they have
opposing effects on plasma membrane localization. Whereas
myristoylation is required for plasma-membrane targeting of
Gpa1, mono-ubiquitination directs the protein from the
plasma membrane to the vacuole where it is degraded (26).
Given that Gpa1 normally exists in both myristoylated and
non-myristoylated forms within the cell (11, 42), we first con-
sidered whether the two types of ubiquitination are dictated by
the myristoylation status of the protein.
Initially we characterized variants of Gpa1 that are either
non-myristoylated or fully myristoylated. Substitution of the
N-terminal Gly residue of Gpa1 yields a protein that cannot be
myristoylated (Gpa1G2A) and, as a consequence, is redirected
from the plasmamembrane to endomembranes and cytoplasm
(Fig. 1,A and B) (10). Gpa1 phosphorylated at serine 200 is also
incapable of being myristoylated,3 and so conversely a non-
phosphorylated mutant (Gpa1S200A) is fully myristoylated (Fig.
1A). We used both of these variants to investigate the require-
ment of myristoylation for ubiquitination of Gpa1.
Because this is the first analysis of a fully myristoylated form
of Gpa1, we documented the functionality of the Gpa1S200A
mutant in vivo. We found that sub-
stitution of serine 200 does not alter
Gpa1 localization as determined by
fluorescence microscopy of a GFP-
tagged protein (Fig. 1B). Gpa1S200A
also exhibits normal pheromone-in-
duced cell division arrest, as deter-
mined by the growth arrest (halo)
assay (Fig. 1C). As a third measure of
signaling competence, we tested the
effect of Gpa1 overexpression on
pheromone-induced gene transcrip-
tion. Overexpression of wild type
Gpa1 dampens pheromone-induced
pathway activation by providing
excess G to sequester free G at
the plasmamembrane.Using a tran-
scription reporter assay (FUS1 pro-
moter, lacZ reporter), we found that
overexpression of Gpa1S200A also
dampens pheromone-induced gene
transcription, comparable with that
observed with overexpression of
wild type Gpa1 (Fig. 1D). We con-
clude that Gpa1S200A is fully myris-
toylated and fully competent to
transmit the pheromone signal.
We then considered whether myr-
istoylation is required for mono-
ubiquitination of Gpa1. To address
this question, we tracked mono-
ubiquitination of protein that is par-
tially myristoylated (Gpa1), non-
myristoylated (Gpa1G2A), or fully
myristoylated (Gpa1S200A). To best detect the mono-ubiquiti-
nated species, we overexpressed Gpa1 in cells lacking the mas-
ter vacuolar protease Pep4 (pep4). In these cells Gpa1 mono-
ubiquitination is evident as a single band that migrates 8–10
kDa higher than the native protein (63 kDa versus 54–56
kDa) as detected with anti-Gpa1 antibodies (supplemental Fig.
1) (26). We found that wild type and fully myristoylated
Gpa1S200A exhibited similar levels ofmono-ubiquitination (Fig.
1E, left). In contrast, non-myristoylated Gpa1G2A lacked any
detectable mono-ubiquitination (Fig. 1E, right). Thus, myris-
toylation appears to be a prerequisite for mono-ubiquitination
of Gpa1.
Next we evaluated the contribution of myristoylation to
poly-ubiquitination. In this case we expressed Gpa1 in cells
harboring a temperature-sensitive allele of CIM3 (cim3-1),
encoding a component of the 26 S proteasome complex (34). In
the cim3-1 strain Gpa1 poly-ubiquitination is evident as a lad-
der of high molecular weight bands. Laddering was not
observed in extracts from cells transformed with empty vector,
indicating that the high molecular weight immunoblot signal
was specific to Gpa1 (supplemental Fig. 1).Wild type Gpa1 and
fullymyristoylatedGpa1S200A exhibited nearly equivalent levels
of poly-ubiquitination (Fig. 1F, left). Likewise, poly-ubiquitina-
tion of Gpa1G2A was clearly visible, albeit diminished (Fig. 1F,
FIGURE 2. An N-terminal polybasic stretch can substitute for Gpa1 myristoylation. A, table of Gpa1 N-ter-
minal mutants and their corresponding sequences. B, strain YGS5 expressing single copy (pRS316) Gpa1 (WT),
Gpa1G2A (G2A), or Gpa1G2A/4K (G2A/4K) were grown at 34 °C to saturation, spotted in serial 2-fold dilutions, and
incubated either at 34 °C or room temperature (RT). C, DIC and GFP fluorescence of strain BY4741 expressing
integrated (pRS406) Gpa1-GFP, Gpa1G2A-GFP, or Gpa1G2A/4K-GFP. D, strain (ste7 gpa1) transformed with
single copy plasmids pRS315-STE7 and either pRS316-GPA1 or pRS316-GPA1G2A/4K analyzed with the phero-
mone-induced growth inhibition assay as described above. E, BY4741 cells expressing FUS1-lacZ reporter and
overexpressing (pAD4M) Gpa1 or Gpa1G2A/4K treated with the indicated concentrations of mating pheromone
for 90 min. Results are the mean  S.E. for four individual experiments each performed in triplicate.
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right). Taken together these data reveal that myristoylation is
required for mono-ubiquitination but not for poly-ubiquitina-
tion of Gpa1.
An N-terminal Polybasic Stretch Can Substitute for Gpa1
Myristoylation—Myristoylation is required for mono-ubiquiti-
nation as well as for plasma membrane targeting of Gpa1, as
noted above. Therefore, it is possible that proper membrane
localization, rather than myristoylation, is required for Gpa1
mono-ubiquitination. To test this possibility we created a
mutant form of Gpa1 that is not myristoylated but is neverthe-
less properly localized at the plasma membrane. Our approach
was similar to one employed byDeschenes and co-workers (44),
who showed that a stretch of basic amino acids can substitute
for lipid acylation and thereby restore membrane localization
to Ras. Accordingly, we introduced a polybasic stretch consist-
ing of four lysine residues close to the N terminus of Gpa1,
where myristoylation and palmitoylation normally occur. We
refer to this mutant as Gpa1G2A/4K, indicating that it contains
four lysine substitutions but lacks the ability to bemyristoylated
(G2A) (Fig. 2A).
We then established the functionality of Gpa1G2A/4K. Cells
that exclusively express non-myristoylated Gpa1G2A are invia-
ble, presumably because G and G no longer co-localize,
allowing the G complex to signal constitutively, resulting in
cell cycle arrest (10). To determine whether Gpa1G2A/4K can
overcome the loss of myristoylation, we expressed the mutant
in cells that lack endogenousGPA1 (strain YGS5). The absence
of Gpa1 ordinarily leads to constitutive signaling and cell cycle
arrest; however, YGS5 is viable at 34 °C because of a tempera-
ture-sensitive mutation that blocks the signal downstream of
the G protein (ste11ts). At the permissive temperature for
growth where signaling is restricted, cells expressing either
Gpa1G2A or Gpa1G2A/4K grew well. At the restrictive tempera-
ture for growth, where signaling proceeds normally, expression
of Gpa1G2A/4K allowed normal growth, whereas Gpa1G2A
caused growth arrest (Fig. 2B). Gpa1G2A/4K is also properly
localized at the plasma membrane as determined by fluores-
cence microscopy, whereas Gpa1G2A localizes diffusely
throughout the cytoplasm (Fig. 2C). Finally, Gpa1G2A/4K is sig-
naling-competent as determined by the halo and transcription-
reporter assays described above, although the cells were
unusually sensitive to pheromone-induced growth arrest
(Fig. 2, D and E). Taken together, these data confirm that
Gpa1G2A/4K is properly localized and functional despite the
absence of myristoylation.
We then used Gpa1G2A/4K to determine whether plasma
membrane localization (in the absence ofmyristoylation) is suf-
ficient for mono-ubiquitination of Gpa1. As shown in Fig. 3,
mono-ubiquitinated Gpa1 was readily detected in both wild
type and pep4 cells. In contrast, we failed to observe anymod-
ification of Gpa1G2A/4K in either cell type (Fig. 3). Gpa14K,
which can be myristoylated, was still mono-ubiquitinated, sug-
gesting that the polybasic stretch itself does not affect Gpa1
mono-ubiquitination. In contrast, poly-ubiquitination of
Gpa1G2A/4K was comparable with that of wild type Gpa1 (Fig.
4), whereas poly-ubiquitination of Gpa14K was enhanced
slightly. We conclude that Gpa1 must be myristoylated to
undergomono-ubiquitination in vivo. In contrast, neithermyr-
istoylation nor plasma membrane targeting is required for
Gpa1 poly-ubiquitination.
Gpa1 Protein Folding Mutants Are Targeted for Poly-ubiq-
uitination but Not Mono-ubiquitination—The data presented
above indicate that mono-ubiquitination requires that Gpa1 is
properly myristoylated. In contrast, poly-ubiquitination is
unaffected by the loss of myristoylation. Thus, we next consid-
ered if poly-ubiquitination instead targets Gpa1 that is mis-
folded. To test this hypothesis, we engineered Gpa1 variants
that are structurally unstable and then compared mono- and
poly-ubiquitination of each variant. Accordingly, we employed
FIGURE 3. Plasma membrane localization is not sufficient for Gpa1 mono-
ubiquitination. pAD4M-GPA1 (WT) or the indicated point mutant expressed
in pep4 or the corresponding isogenic wild type strain and analyzed by
immunoblotting with anti-Gpa1 antibodies, as described above. Top and bot-
tom panels are identical except for exposure time. The slower mobility of
G2A/4K relative to G2A is presumed to occur because of the effect of substi-
tuting four lysine residues on SDS-PAGE mobility of the protein.
FIGURE 4. Plasma membrane localization is sufficient for Gpa1 poly-ubiq-
uitination. pAD4M-GPA1 (WT) or the indicated point mutant expressed in
cim3-1 or the corresponding isogenic wild type strain and analyzed by immu-
noblotting with anti-Gpa1 antibodies as described above. Quantitation of the
poly-ubiquitinated form of Gpa1 (laddering) relative to native Gpa1 is the
average  S.D. for three independent experiments. Top and bottom panels
are identical except for exposure time.
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a protein modeling suite,Medusa (37), to identify Gpa1 desta-
bilizing mutations based on the three-dimensional structure of
the protein. The structure of Gpa1 has not been determined;
however, the structure of human Gi, which shares 67%
sequence similarity with yeast Gpa1, has been solved to high
resolution by x-ray crystallography (PDB code 1agr) (40).
Benchmarked on a large set of experimentally characterized
mutations, Medusa has been used to accurately recapitulate
changes in the structural stability of proteins upon amino acid
substitution (37–39). Using this method, we identified five res-
idues within the hydrophobic core of the protein that are con-
served between yeast and human, substitution of which (to ala-
nine) is predicted to destabilize Gpa1 (Table 1). Mutations that
interfere with the catalytic or known protein binding regions of
G were avoided.
We then examined all five Gpa1 mutants in the proteasome-
deficient cim3-1 cells and compared the levels of poly-ubiquiti-
nation by immunoblotting. For every Gpa1 mutant, poly-ubiq-
uitination was elevated relative to the wild type protein (Fig.
5A). In contrast, Gpa1 mono-ubiquitination was unaffected or
reduced in every case (Fig. 5B). These data indicate that mis-
folded Gpa1 is targeted for poly-ubiquitination rather than
mono-ubiquitination.
Rsp5 Is Necessary and Sufficient for Mono-ubiquitination of
Gpa1—The data presented above indicate that mono- and
poly-ubiquitination are distinct processes with distinct sub-
strate specificity requirements and unique functional conse-
quences forGpa1.Whereas the fullymature and fullymyristoy-
lated G protein is mono-ubiquitinated and delivered to the
vacuole, misfolded Gpa1 is instead poly-ubiquitinated and
degraded by the proteasome. As a further test of this model, we
sought to determine whether the two types of ubiquitination
employ different ubiquitinating enzymes. Two lines of evidence
suggest that Rsp5 might be involved in Gpa1 ubiquitination.
First, Rsp5 is a HECT-type E3 ubiquitin ligase involved in
mono-ubiquitination and endocytosis of multiple membrane-
localized proteins including the pheromone receptor Ste2. Sec-
ond, Rsp5 is membrane-bound in vivo (45, 46). To test the
hypothesis that Rsp5 is required for mono-ubiquitination of
Gpa1, we overexpressed Gpa1 in a strain where RSP5 gene
expression is repressed upon the addition of doxycycline
(TetO7-RSP5). The data were compared with a wild type strain
in which the promoter element is present but not attached to
any open reading frame (TetO7-WT) (35). As shown in Fig. 6,
we observed a loss of Gpa1 mono-ubiquitination after RSP5
repression but no change in untreated cells or in the control
TetO7-WT cells with or without doxycycline treatment (Fig.
6A). Conversely, we observed a significant increase in Gpa1
poly-ubiquitination after RSP5 repression. Thus, Gpa1
mono-ubiquitination and poly-ubiquitination are recipro-
cally regulated in the absence of
Rsp5. Because mono-ubiquitina-
tion serves as an endocytosis and
vacuolar sorting signal, we tested
the ability of Gpa1 to undergo vacu-
olar translocation in the presence or
absence of Rsp5. Whereas Gpa1-
GFP is normally detected in the vac-
uolar compartment, vacuolar Gpa1
was barely detectable after Rsp5
repression (Fig. 6B). Thus, Rsp5 is
required for mono-ubiquitination
and proper translocation of Gpa1 to
the vacuole.
To further characterize the struc-
tural determinants necessary for
Gpa1 mono-ubiquitination, we ex-
amined the protein for potential
Rsp5 docking sites. Rsp5 contains
WW protein interaction domains
that bind and recruit substrates or
substrate adaptor proteins contain-
ing one or more short PY motifs
(PPXY) within their primary struc-
ture (47, 48).However, the PXYpor-
tion of the motif is the minimal
FIGURE 5. Gpa1 poly-ubiquitination, but not mono-ubiquitination, is elevated for protein folding
mutants. A, immunoblot of mutant cim3-1 and the isogenic wild type strain transformed with plasmid pAD4M-
GPA1 (WT) or the indicated point mutant grown at the restrictive temperature of 37 °C for 4 h. Whole cell
extracts were resolved by 10% SDS-PAGE and immunoblotting with anti-Gpa1 antibodies. B, mutant pep4
and the isogenic wild type strain transformed with plasmid pAD4M-GPA1 or the indicated point mutant and
grown to early-log phase at 30 °C. The difference in exposures between cim3-1 and pep4 experiments is
required to ensure visualization of either the mono-ubiquitin band (which is in close proximity to the Gpa1
bands) or poly-ubiquitin laddering. Quantitation of the poly-ubiquitinated (cim3-1 strain) or mono-ubiquiti-
nated (pep4 strain) Gpa1 relative to native Gpa1 is the average  S.D. for at least three independent experi-
ments. C, ste7 gpa1 cells expressing pRS315-STE7 and pRS316-GPA1 or the indicated mutant were grown to
early log phase and analyzed by immunoblotting with anti-Gpa1 antibodies.
TABLE 1
Relative free energies of Gpa1 protein fold-destabilizing mutations
Medusa protein modeling software was used in combination with the high resolu-
tion crystal structure of human Gi (PDB code 1agr) to identify a set of five point
mutations that are conserved in the yeast G protein Gpa1 and predicted to create
a variety of protein fold stabilities relative to thewild type protein (see “Experimental
Procedures”). The structural stability of the mutant protein is computed using the
relaxed structure, and the mutation-induced stability change (G) is obtained by
subtracting the wild type stability. Mutations with higher G values are predicted
to have the greatest negative effect on Gi protein fold stability.






a Relative to wild type.
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requirement for establishing an
interactionwith Rsp5, whereas non-
polar hydrophobic residues can be
tolerated at the first position of the
motif (e.g. LPXY or APXY) (47, 48).
Gpa1 contains a single non-canoni-
cal PY motif (FPDY) that contains a
nonpolar hydrophobic residue in
position 1. To determine whether
the FPDY segment contributes to
Rsp5-mediated ubiquitination, we
replaced the conserved proline and
tyrosine with alanine (FADA 
PY). These substitutions resulted
in a significant but incomplete
reduction in Gpa1 mono-ubiquiti-
nation in vivo (Fig. 6C). Taken
together these data reveal that Rsp5
expression as well as an Rsp5 bind-
ing motif is necessary for the proper
mono-ubiquitination of Gpa1.
To directly determine whether
Rsp5 ubiquitinates Gpa1, we con-
ducted an in vitro ubiquitination
assay using purified proteins. To
this end, we combined purified
recombinant Rsp5 or catalytically-
inactive Rsp5-(C777A) with Uba1
activating enzyme, Ubc5 conjugat-
ing enzyme, ubiquitin, Gpa1, and
ATP. We allowed the in vitro reac-
tion to proceed for 30 min after
which we analyzed Gpa1 ubiquiti-
nation by immunoblotting. When
incubated with Rsp5, Gpa1 mono-
ubiquitination was detectable as a
distinct band supershifted relative
to native Gpa1 (Fig. 7). In contrast,
Gpa1 incubated with the catalyti-
cally inactive Rsp5 mutant (Rsp5-
(C/A)) or without E1 activating
enzyme showed no evidence of
ubiquitination (Fig. 7). Although
less obvious, some Rsp5-dependent
poly-ubiquitination of Gpa1 was
also observed in the reaction. Taken
together these data reveal that Rsp5
is both necessary and sufficient for
the mono-ubiquitination of Gpa1.
Furthermore, it appears that a dis-
tinct enzyme is needed for Gpa1
poly-ubiquitination and that such
an enzyme acts preferentially on
misfolded protein.
DISCUSSION
The yeast G protein  subunit,
Gpa1, undergoes both mono- and
FIGURE 6. The ubiquitin ligase Rsp5 is required for Gpa1 mono-ubiquitination in vivo. A, cells harboring a
doxycycline-repressible promoter attached to the RSP5 open reading frame (TetO7-RSP5) or to a non-expressible
genetic element (TetO7-WT) were transformed with the overexpression plasmid pAD4M-GPA1 or empty vector.
Transformants were grown to early log phase and then split, and half were treated with doxycycline (Dox) at 10
g/ml for 16 h, diluted in doxycycline-containing or free medium, and grown to early log phase. Cells were har-
vested, lysed, and analyzed by immunoblotting with anti-Gpa1 antibodies. B, DIC and GFP fluorescence of strain
TetO7-WT or TetO7-RSP5 harboring pRS405-GPA1-GFP-pep4 integrated into the PEP4 locus, thereby disrupting
expression of the vacuolar protease Pep4. C, mono-ubiquitination of overexpressed wild type (WT) and non-myris-
toylated (G2A) Gpa1 was compared by Gpa1 immunoblotting with that of a Gpa1 double mutant P407A/Y409A
(PY) lacking the essential residues of a putative Rsp5 binding motif (PY motif) (left). Quantitation of the resulting
immunoblots was performed in triplicate using cells from three different transformants.
G Protein Mono-ubiquitination by the Rsp5 Ubiquitin Ligase
MARCH 27, 2009 • VOLUME 284 • NUMBER 13 JOURNAL OF BIOLOGICAL CHEMISTRY 8947
poly-ubiquitination. Either type of ubiquitination results in
alternate Gpa1 trafficking outcomes; whereas mono-ubiquiti-
nation promotes translocation to the vacuole, poly-ubiquitina-
tion results in translocation to the proteasome. We have used
Gpa1 as a model protein to investigate the factors underlying
the two types of ubiquitination. We find that mutants that are
not myristoylated are no longer mono-ubiquitinated but still
are poly-ubiquitinated in vivo. Conversely, we find that variants
of Gpa1 engineered to be unstable are less likely to be mono-
ubiquitinated and more likely poly-ubiquitinated. Finally, we
show that the ubiquitin ligase Rsp5 is necessary forGpa1mono-
ubiquitination in vivo and is sufficient for this process to occur
in vitro. We conclude that Gpa1 mono- and poly-ubiquitina-
tion are functionally distinct processes controlled by different
E3 ligases, each with distinct substrate requirements; whereas
Rsp5-catalyzed mono-ubiquitination targets myristoylated G
protein to the vacuole, poly-ubiquitination by a different E3
ligase targets misfolded protein to the proteasome (Fig. 8).
We have identified Rsp5 as the ligase responsible for mono-
ubiquitination and vacuolar translocation of Gpa1. Rsp5 is a
membrane-bound E3 ligase responsible for ubiquitination of
many substrates including the G protein-coupled receptor
Ste2. Whereas Ste2 mono-ubiquitination occurs in a phero-
mone-stimulated manner (45, 46), Gpa1 mono-ubiquitination
appears to be a constitutive process. Mono-ubiquitination in
either case contributes to clearing of fully mature and fully
functional protein from the plasma membrane. Just as Ste2
must be present at the cell surface and competent to bind pher-
omone, we propose that Gpa1 must be myristoylated and pres-
ent at the plasma membrane to be mono-ubiquitinated. The
possibility exists that mono-ubiquitination of Gpa1 also occurs
at endomembranes.
The precise role of myristoylation during Gpa1 mono-ubiq-
uitination is not clear. We have reconstituted Rsp5-catalyzed
mono-ubiquitination in vitro using Gpa1 purified from E. coli,
which lacks the N-myristoyltransferase Nmt1 and, therefore,
produces non-myristoylatedGprotein. Because Rsp5 can ubiq-
uitinateGpa1 in the absence ofmyr-
istoylation in vitro, it is possible that
the absence of Gpa1G2A/4K mono-
ubiquitination may be due to the
orientation of the G protein relative
to the membrane; we consider this
plausible because the interaction
of plasma membrane with myris-
tate and the N-terminal polybasic
stretch are likely to be different.
Alternatively, myristoylation may
be necessary to enhance an other-
wise weak interaction between
Gpa1 and Rsp5.
We have shown further that
mutation of an Rsp5 binding or PY
motif in Gpa1 reduces mono-ubiq-
uitination. In contrast, recent evi-
dence indicates that many Rsp5
substrates lack a clear PYmotif, and
binding to Rsp5 is instead provided
by an adaptor protein that medi-
ates functional interaction between
the substrate and the ligase (49).
FIGURE 7. Rsp5 ubiquitinates Gpa1 in vitro. Purified recombinant wild type
or catalytically-inactive Rsp5 (Rsp5-(C/A)), Gpa1, and Uba1 (E1) were incu-
bated as indicated in the presence of Ubc5, ATP, and ubiquitin for 30 min at
room temperature followed by quenching with SDS-PAGE loading buffer
containing DTT. Samples were resolved by 10% SDS-PAGE and immunoblot-
ting with anti-Gpa1 antibody (top panels). The nitrocellulose blot was stained
with Coomassie Blue to detect Rsp5 and Uba1.
FIGURE 8. Determinants of Gpa1 mono- and poly-ubiquitination. The fully myristoylated and fully mature
form of Gpa1 (e.g. Gpa1S200A) is mono-ubiquitinated and translocated to the vacuole for degradation (enriched
in pep4 cells). Non-myristoylated (e.g. Gpa1G2A or Gpa1G2A/4K) or misfolded Gpa1 is poly-ubiquitinated and
degraded by the proteasome. Rsp5 is necessary and sufficient for Gpa1 mono-ubiquitination. The enzyme
responsible for Gpa1 poly-ubiquitination is unknown. PM, plasma membrane.
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Although our data indicate that an adaptor is not necessary for
Gpa1 mono-ubiquitination, the possibility remains that an
adaptor protein may enhance ubiquitination by Rsp5 in vivo.
Interestingly, cells lacking Rsp5 exhibit a dramatic increase
inGpa1 poly-ubiquitination. In the absence of Rsp5, poly-ubiq-
uitinationmay be allowed to occur predominantly and, thereby,
compensate for the loss of vacuolar degradation. Alternatively,
Rsp5 may be involved in down-regulating Gpa1 poly-ubiquiti-
nation through direct targeting of another ubiquitin ligase. In
any case, an additional E3 ligase other than Rsp5 is likely
responsible for poly-ubiquitination of Gpa1 in vivo. We have
demonstrated that Gpa1 misfolding mutants may be more sus-
ceptible to poly-ubiquitination by such a ligase. To this end we
used the Medusa protein-modeling suite, which has been pre-
viously shown to accurately predict mutation-induced differ-
ences in protein folding (38, 39). The success of this approach
relied in part on the high resolution crystal structure of Gi, a
protein with a high degree of similarity to Gpa1. Therefore, the
mutations we have described here may be useful in studying
Gi as a potential ubiquitination substrate. Notably, Gi has
been shown to be down-regulated by the overexpression of
GIPN (GAIP interacting protein N terminus), a putative E3
ubiquitin ligase that is localized to the plasma membrane (50).
TheMedusa protein-modeling suite could also be used to study
the effects of protein misfolding on other signaling proteins
that share high similarity between organisms. Candidates
include numerous ubiquitinated signaling components in yeast
and mammals (8, 51, 52), including G protein-coupled recep-
tors (20–23, 53–59) and G proteins (25, 53, 60–63).
Historically, investigation of G protein modification has
focused on fatty acylation. Many cellular proteins are poly-
ubiquitinated and subsequently degraded by the proteasome.
More rarely, proteins are mono-ubiquitinated and targeted for
endocytosis. However, it has remained unclear how proteins
are selected for one or the other form of ubiquitination. Here
we have identified functional determinants leading to mono-
versus poly-ubiquitination of a single protein substrate, the G
protein  subunit Gpa1. We have shown that the fully mature,
fully myristoylated form of the protein undergoes mono-
ubiquitination, whereas misfolded protein is instead poly-
ubiquitinated. We have shown further that Rsp5 is both nec-
essary and sufficient for the mono-ubiquitination and
vacuolar translocation of Gpa1. Finally we have demon-
strated how a protein fold prediction algorithm can be used
to improve understanding of G protein ubiquitination and
its relationship to protein fold stability. Given the ubiquity of
G proteins as signal transducers and of ubiquitination as a
mechanism of cell regulation, the integration of genetic,
biochemical, and computational modeling approaches
employed here should prove useful in the study of other G pro-
teins as substrates for ubiquitination.
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